Whey protein ( DrugBank: - )

---

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2
96	クローン病	2

6. パーキンソン病

---

臨床試験数 : 2,307 /  薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05523791 (ClinicalTrials.gov)	January 1, 2022	17/8/2022	Whey Protein Supplementation in Patients With Parkinson's Disease	Can we Add Whey Protein Supplementation in Patients With Parkinson's Disease Without Interfering With Levodopa Response?	Parkinson Disease	Dietary Supplement: Fortiral;Dietary Supplement: Mg++	Ospedale Generale Di Zona Moriggia-Pelascini	NULL	Completed	60 Years	N/A	All	51	N/A	Italy
2	NCT01662414 (ClinicalTrials.gov)	April 2011	7/8/2012	Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease	Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease: Changes in Biomarkers of Oxidative Stress, Profiles of Plasma Amino Acids and Their Derivatives and Brain Function	Parkinson Disease;Parkinsonian Disorders;Basal Ganglia Diseases;Brain Diseases;Central Nervous System Diseases;Nervous System Diseases;Movement Disorders;Neurodegenerative Diseases	Dietary Supplement: Whey protein;Dietary Supplement: Soy protein	Chulalongkorn University	NULL	Completed	30 Years	80 Years	Both	38	Phase 4	Thailand

96. クローン病

---

臨床試験数 : 2,442 /  薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01957423 (ClinicalTrials.gov)	March 2012	24/9/2013	Immune Response Regulation and Nutritional Status of the Crohn's Disease Patients.	Immune Response Regulation and Nutritional Status of Crohn's Disease Patients Under Anti-TNF-alpha and Azathioprine Therapy.	Crohn's Disease	Dietary Supplement: Whey protein;Dietary Supplement: Soy protein	University of Campinas, Brazil	Fundação de Amparo à Pesquisa do Estado de São Paulo	Completed	N/A	N/A	Both	41	N/A	Brazil
2	NCT00838149 (ClinicalTrials.gov)	November 2005	5/2/2009	Effect of Glutamine on Intestinal Permeability in Crohn's Disease	Effect of Glutamine Supplementation on the Structure and Function of the Mucosa of Small Intestine in Crohn's Disease: A Randomized Controlled Trial	Crohn's Disease	Dietary Supplement: Glutamine;Dietary Supplement: Whey protein	All India Institute of Medical Sciences, New Delhi	NULL	Completed	15 Years	60 Years	Both	30	Phase 1	India